Clinical Trial Update: Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating capecitabine in combination with simvastatin for locally advanced rectal adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of Rectum
• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Samsung Medical Center | Conditions: Adenocarcinoma of Rectum | Phase 2 | Status: UNKNOWN